277 related articles for article (PubMed ID: 17490878)
1. Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
Hasegawa T; Bai J; Dai J; Bai L; Sakai J; Nishizawa S; Bai Y; Kikuchi M; Abe M; Yamori T; Tomida A; Tsuruo T; Hirose K; Ando M
Bioorg Med Chem Lett; 2007 Jul; 17(13):3722-8. PubMed ID: 17490878
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of some taxoids as multidrug resistance modulator.
Hasegawa T; Bai J; Zhang S; Wang J; Matsubara J; Kawakami J; Tomida A; Tsuruo T; Hirose K; Sakai J; Kikuchi M; Abe M; Ando M
Bioorg Med Chem Lett; 2007 Feb; 17(4):1122-6. PubMed ID: 17239597
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
4. An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents.
Kumar D; Sundaree S; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 Aug; 19(15):4492-4. PubMed ID: 19559607
[TBL] [Abstract][Full Text] [Related]
5. Bioactive cardenolides from the stems and twigs of Nerium oleander.
Zhao M; Bai L; Wang L; Toki A; Hasegawa T; Kikuchi M; Abe M; Sakai J; Hasegawa R; Bai Y; Mitsui T; Ogura H; Kataoka T; Oka S; Tsushima H; Kiuchi M; Hirose K; Tomida A; Tsuruo T; Ando M
J Nat Prod; 2007 Jul; 70(7):1098-103. PubMed ID: 17595134
[TBL] [Abstract][Full Text] [Related]
6. Coumarin derivatives with tumor-specific cytotoxicity and multidrug resistance reversal activity.
Kawase M; Sakagami H; Motohashi N; Hauer H; Chatterjee SS; Spengler G; Vigyikanne AV; Molnár A; Molnár J
In Vivo; 2005; 19(4):705-11. PubMed ID: 15999537
[TBL] [Abstract][Full Text] [Related]
7. Novel multidrug resistance reversal agents.
Berger D; Citarella R; Dutia M; Greenberger L; Hallett W; Paul R; Powell D
J Med Chem; 1999 Jun; 42(12):2145-61. PubMed ID: 10377220
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents.
Zou ZH; Lan XB; Qian H; Huang WL; Li YM
Bioorg Med Chem Lett; 2011 Oct; 21(19):5934-8. PubMed ID: 21843940
[TBL] [Abstract][Full Text] [Related]
9. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.
Kars MD; Işeri OD; Gunduz U; Molnar J
Chemotherapy; 2008; 54(3):194-200. PubMed ID: 18560226
[TBL] [Abstract][Full Text] [Related]
10. In vitro cytotoxic activity of novel protoflavone analogs - selectivity towards a multidrug resistant cancer cell line.
Danko B; Martins A; Chuang DW; Wang HC; Amaral L; Molnár J; Chang FR; Wu YC; Hunyadi A
Anticancer Res; 2012 Jul; 32(7):2863-9. PubMed ID: 22753749
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer.
Li Y; Zhang HB; Huang WL; Li YM
Bioorg Med Chem Lett; 2008 Jun; 18(12):3652-5. PubMed ID: 18502125
[TBL] [Abstract][Full Text] [Related]
12. A new taxoid from a callus culture of Taxus cuspidata as an MDR reversal agent.
Dai J; Bai J; Hasegawa T; Nishizawa S; Sakai J; Oka S; Kiuchi M; Hirose K; Tomida A; Tsuruo T; Li M; Ando M
Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):306-9. PubMed ID: 16508182
[TBL] [Abstract][Full Text] [Related]
13. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
Nakagawa-Goto K; Bastow KF; Chen TH; Morris-Natschke SL; Lee KH
J Med Chem; 2008 Jun; 51(11):3297-303. PubMed ID: 18473435
[TBL] [Abstract][Full Text] [Related]
14. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship of newly synthesized quinoline derivatives for reversal of multidrug resistance in cancer.
Suzuki T; Fukazawa N; San-nohe K; Sato W; Yano O; Tsuruo T
J Med Chem; 1997 Jun; 40(13):2047-52. PubMed ID: 9207946
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery.
Miller ML; Roller EE; Zhao RY; Leece BA; Ab O; Baloglu E; Goldmacher VS; Chari RV
J Med Chem; 2004 Sep; 47(20):4802-5. PubMed ID: 15369381
[TBL] [Abstract][Full Text] [Related]
17. Bioactive secolignans from Peperomia dindygulensis.
Wu JL; Li N; Hasegawa T; Sakai J; Mitsui T; Ogura H; Kataoka T; Oka S; Kiuchi M; Tomida A; Turuo T; Li M; Tang W; Ando M
J Nat Prod; 2006 May; 69(5):790-4. PubMed ID: 16724842
[TBL] [Abstract][Full Text] [Related]
18. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.
Labbozzetta M; Notarbartolo M; Poma P; Maurici A; Inguglia L; Marchetti P; Rizzi M; Baruchello R; Simoni D; D'Alessandro N
Ann N Y Acad Sci; 2009 Feb; 1155():278-83. PubMed ID: 19250217
[TBL] [Abstract][Full Text] [Related]
19. Bioactive pregnanes from Nerium oleander.
Bai L; Wang L; Zhao M; Toki A; Hasegawa T; Ogura H; Kataoka T; Hirose K; Sakai J; Bai J; Ando M
J Nat Prod; 2007 Jan; 70(1):14-8. PubMed ID: 17253842
[TBL] [Abstract][Full Text] [Related]
20. Tumour-specific cytotoxicity and MDR-reversal activity of dihydropyridines.
Engi H; Sakagami H; Kawase M; Parecha A; Manvar D; Kothari H; Adlakha P; Shah A; Motohashi N; Ocsovszki I; Molnár J
In Vivo; 2006; 20(5):637-43. PubMed ID: 17091771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]